Peripheral blood mononuclear cells (PBMCs) were labeled with a combination of the following mAbs: CD3 (SP34–2), CD4 (L200), CD8 (SK1), CD21 (B-ly4), CD27 (M-T271), CD28 (CD28.2), CD95 (DX2), and IgM (G20–127) (BD Pharmingen, San Jose, CA), CD20 (2H7) (Biolegend, Inc., San Diego, CA) and FOXP3 (236A/E7) (eBioscience, Inc., San Diego, CA). Based on previous reports, which suggest that long-term allograft survival is associated with a predominance of immature B lymphocyte reconstitution,12 (link),13 (link) CD3-CD20+CD21+IgM+ or CD3-CD20+CD21-CD27+ B cells representing immature or mature B cell phenotypes, respectively, were monitored before and after conditioning. The fluorescence of the stained samples was analyzed using FACSverse (BD Biosciences, San Jose, CA) and Accuri flow cytometers (BD PharMingen), and FlowJo software (Tree Star, Inc., Ashland, OR).